These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 32877753)

  • 1. Glucagon-like peptide 1 treatment reverses vascular remodelling by downregulating matrix metalloproteinase 1 expression through inhibition of the ERK1/2/NF-κB signalling pathway.
    Fan SH; Xiong QF; Wang L; Zhang LH; Shi YW
    Mol Cell Endocrinol; 2020 Dec; 518():111005. PubMed ID: 32877753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucagon-like peptide-1 attenuates cardiac hypertrophy via the AngII/AT1R/ACE2 and AMPK/mTOR/p70S6K pathways.
    Wang J; Fan S; Xiong Q; Niu Y; Zhang X; Qin J; Shi Y; Zhang L
    Acta Biochim Biophys Sin (Shanghai); 2021 Aug; 53(9):1189-1197. PubMed ID: 34357376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dipeptidyl peptidase 4 inhibitor sitagliptin protects endothelial function in hypertension through a glucagon-like peptide 1-dependent mechanism.
    Liu L; Liu J; Wong WT; Tian XY; Lau CW; Wang YX; Xu G; Pu Y; Zhu Z; Xu A; Lam KS; Chen ZY; Ng CF; Yao X; Huang Y
    Hypertension; 2012 Sep; 60(3):833-41. PubMed ID: 22868389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of dipeptidyl peptidase 4 inhibition on arterial blood pressure is context dependent.
    Jackson EK; Mi Z; Tofovic SP; Gillespie DG
    Hypertension; 2015 Jan; 65(1):238-49. PubMed ID: 25368027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toll-like receptor 4 contributes to vascular remodelling and endothelial dysfunction in angiotensin II-induced hypertension.
    Hernanz R; Martínez-Revelles S; Palacios R; Martín A; Cachofeiro V; Aguado A; García-Redondo L; Barrús MT; de Batista PR; Briones AM; Salaices M; Alonso MJ
    Br J Pharmacol; 2015 Jun; 172(12):3159-76. PubMed ID: 25712370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exendin-4 Prevents Vascular Smooth Muscle Cell Proliferation and Migration by Angiotensin II via the Inhibition of ERK1/2 and JNK Signaling Pathways.
    Nagayama K; Kyotani Y; Zhao J; Ito S; Ozawa K; Bolstad FA; Yoshizumi M
    PLoS One; 2015; 10(9):e0137960. PubMed ID: 26379274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of linagliptin and liraglutide on glucose- and angiotensin II-induced collagen formation and cytoskeleton degradation in cardiac fibroblasts in vitro.
    Wang XW; Zhang FX; Yang F; Ding ZF; Agarwal N; Guo ZK; Mehta JL
    Acta Pharmacol Sin; 2016 Sep; 37(10):1349-1358. PubMed ID: 27498780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dipeptidyl Peptidase 4 Inhibition Alleviates Shortage of Circulating Glucagon-Like Peptide-1 in Heart Failure and Mitigates Myocardial Remodeling and Apoptosis via the Exchange Protein Directly Activated by Cyclic AMP 1/Ras-Related Protein 1 Axis.
    Aoyama M; Kawase H; Bando YK; Monji A; Murohara T
    Circ Heart Fail; 2016 Jan; 9(1):e002081. PubMed ID: 26721911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An interaction between glucagon-like peptide-1 and adenosine contributes to cardioprotection of a dipeptidyl peptidase 4 inhibitor from myocardial ischemia-reperfusion injury.
    Ihara M; Asanuma H; Yamazaki S; Kato H; Asano Y; Shinozaki Y; Mori H; Minamino T; Asakura M; Sugimachi M; Mochizuki N; Kitakaze M
    Am J Physiol Heart Circ Physiol; 2015 May; 308(10):H1287-97. PubMed ID: 25747753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liraglutide attenuates high glucose-induced abnormal cell migration, proliferation, and apoptosis of vascular smooth muscle cells by activating the GLP-1 receptor, and inhibiting ERK1/2 and PI3K/Akt signaling pathways.
    Shi L; Ji Y; Jiang X; Zhou L; Xu Y; Li Y; Jiang W; Meng P; Liu X
    Cardiovasc Diabetol; 2015 Feb; 14():18. PubMed ID: 25855361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genistein inhibits Ang II-induced CRP and MMP-9 generations via the ER-p38/ERK1/2-PPARγ-NF-κB signaling pathway in rat vascular smooth muscle cells.
    Xu L; Liu JT; Li K; Wang SY; Xu S
    Life Sci; 2019 Jan; 216():140-146. PubMed ID: 30452971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GLP-1 attenuates Ang II-induced proliferation and migration in rat aorta smooth muscle cells
    Xiong QF; Fan SH; Zhang X; Niu Y; Li XW; Shi YW; Zhang LH
    Pharmazie; 2018 Dec; 73(12):692-699. PubMed ID: 30522551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucagon-like peptide-1 (GLP-1) mediates the protective effects of dipeptidyl peptidase IV inhibition on pulmonary hypertension.
    Wang J; Yu M; Xu J; Cheng Y; Li X; Wei G; Wang H; Kong H; Xie W
    J Biomed Sci; 2019 Jan; 26(1):6. PubMed ID: 30634956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Smooth muscle-specific TMEM16A expression protects against angiotensin II-induced cerebrovascular remodeling via suppressing extracellular matrix deposition.
    Zeng XL; Sun L; Zheng HQ; Wang GL; Du YH; Lv XF; Ma MM; Guan YY
    J Mol Cell Cardiol; 2019 Sep; 134():131-143. PubMed ID: 31301303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucagon-like peptide 1 reverses myocardial hypertrophy through cAMP/PKA/RhoA/ROCK2 signaling.
    Fan S; Xiong Q; Zhang X; Zhang L; Shi Y
    Acta Biochim Biophys Sin (Shanghai); 2020 Jun; 52(6):612-619. PubMed ID: 32386193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LOX-1, a bridge between GLP-1R and mitochondrial ROS generation in human vascular smooth muscle cells.
    Dai Y; Mercanti F; Dai D; Wang X; Ding Z; Pothineni NV; Mehta JL
    Biochem Biophys Res Commun; 2013 Jul; 437(1):62-6. PubMed ID: 23806684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucagon-Like Peptide-1 Mediates the Protective Effect of the Dipeptidyl Peptidase IV Inhibitor on Renal Fibrosis via Reducing the Phenotypic Conversion of Renal Microvascular Cells in Monocrotaline-Treated Rats.
    Xu J; Wang J; Cheng Y; Li X; He M; Zhu J; Han H; Wei G; Kong H; Xie W; Wang H; Zuo X
    Biomed Res Int; 2018; 2018():1864107. PubMed ID: 29607314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of extracellular signal-regulated kinases ameliorates hypertension-induced renal vascular remodeling in rat models.
    Jing L; Zhang J; Sun J; Guo F; An X; Yang K; Li PA
    Int J Mol Sci; 2011; 12(12):8333-46. PubMed ID: 22272075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p38 Map kinase regulates vascular smooth muscle cell collagen synthesis by angiotensin II in SHR but not in WKY.
    Touyz RM; He G; El Mabrouk M; Schiffrin EL
    Hypertension; 2001 Feb; 37(2 Pt 2):574-80. PubMed ID: 11230337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute hemodynamic and renal effects of glucagon-like peptide 1 analog and dipeptidyl peptidase-4 inhibitor in rats.
    Zhou X; Huang CH; Lao J; Pocai A; Forrest G; Price O; Roy S; Kelley DE; Sullivan KA; Forrest MJ
    Cardiovasc Diabetol; 2015 Mar; 14():29. PubMed ID: 25888997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.